Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02382250 · ClinicalTrials.gov registry record
Relationship Between Diet, Lifestyle, and the Severity of Coronary Artery Disease
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 440
- Enrollment target
NCT02382250: Completed study, sponsored by NYU Langone Health.
NCT02382250 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 440 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02382250 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 440 participants
- Enrollment target
Study Summary
This study is a prospective study of patients referred for coronary angiography at Bellevue Hospital Center and NYU Langone Medical Center. Subjects enrolled in this study will complete two one-page questionnaires, including information about diet, lifestyle, perceptions of health and perceived barriers to healthy lifestyles. Patients will be contacted at one and six months following their procedure to complete follow-up questionnaires to assess changes in diet and perceptions of their health after knowing the results of their coronary angiogram. The primary outcome measure will be change in dietary patterns/perception of lifestyle between baseline and one- month and six-month follow-up. Secondary measures will include association between dietary patterns/perception of lifestyle and degree of CAD and socioeconomic status.
Interventions
- BEHAVIORAL Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2015-02-01 |
| Est. Completion | 2017-08-02 |
What the finished NCT02382250 record still lists
NCT02382250 is an observational study that tracks outcomes without assigning an intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT02382250 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02382250 about?
NCT02382250 is a clinical study titled "Relationship Between Diet, Lifestyle, and the Severity of Coronary Artery Disease". This study is a prospective study of patients referred for coronary angiography at Bellevue Hospital Center and NYU Langone Medical Center. Subjects enrolled in this study will complete two one-page questionnaires, including information about diet, lifestyle, perceptions of health and perceived barr...
What is the current status of trial NCT02382250?
This trial is currently completed. The enrollment target is 440 participants. The study started on 2015-02-01. Estimated completion is 2017-08-02.
What interventions are being tested in trial NCT02382250?
The interventions under investigation include: Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT02382250?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
- NCT05602194 · 440 participants · Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
- NCT05624879 · 440 participants · NA
Accelerated Resolution Therapy for Early Maladaptive Grief
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI